Among the drugs used in withdrawal treatments, ibogaine is unique. Most substances administered to patients in rehab are intended to temporarily allay withdrawal pains. The name of the practice, “substitution therapy,” already implies its flaws (ones with which Juliana was well acquainted). Ibogaine treatment, in contrast, goes after the addiction itself. It puts people into what’s often described as a “waking dream” state, with effects lasting for more than 10 hours.
“It’s not a hallucinogen like LSD. It’s not like you’re sitting there awake watching the trails on the wall,” describes Dana Beal, one of the world’s leading ibogaine activists who has experienced the effects of ibogaine firsthand. “You close your eyes and go into a waking dream. You’re paralyzed because you can’t summon the will to move. You just want to lie in a quiet room, left alone to review your lifetime of memories.”
In one small study, published in The American Journal of Drug and Alcohol Abuse in 2018, 50 percent of patients reported not using opioids in the previous 30 days at the three-month check-up following their ibogaine treatment. In comparison, says Ken Alper, associate professor of psychiatry and neurology at NYU School of Medicine, one-third to half of patients fail to even complete detoxification treatment using methadone, buprenorphine, and klonopin, today’s three most common drugs for opioid withdrawal symptoms. Among the people who do complete detoxification with these drugs, roughly half are still sober after four to five months.
“[Ibogaine] is the anti-drug,” says Beal, who along with researchers Howard Lotsof and Norma Alexander, studied ibogaine’s therapeutic effects. “You come out and you don’t want to do any more ibogaine, and you don’t want to do a lot of drugs after taking ibogaine.”